Advertisement Platform Technology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
close icon


Advanced Nanomedicine for Oncology, Dermatology and Neurology Indications

More info about ADVANCELL

Platform Technology


Research and development (R&D) activities at ADVANCELL are very focused on generating new high-potential product candidates by creating new nanomedicines by leveraging its innovative technology.

ADVANCELL’s technology enables new and improved formulations of existing active principles by encapsulating them in nanosystems based on its technology, to improve delivery of drugs to the appropriate site and opens up new routes of administration. Encapsulation of active molecules is also preserving their integrity and activity.

The technology has been initially developed at the University of Santiago de Compostela in Spain and is extensively patent protected. ADVANCELL has further developed and expanded the application areas of the technology so that it can now be applied on an industrial scale.

The company is actively expanding its portfolio of product candidates to exploit the full potential of the technology and to create new products with differentiating properties in efficacy, safety and other patient benefits focusing primarily in the areas of dermatology and oncology.

The technology has distinct and differentiating competitive advantages. It can significantly improve the bioavailability of complex molecules due to its sub-micrometric size and adhesive systems for a higher time of contact to skin.

It is also flexible, encapsulating a broad range of active principles and its systems can be adjusted to achieve desired properties.

In addition, the technology is robust and versatile, with key features such as:

  • Chemical stability and solubility of the active molecule
  • High drug loadings can be achieved
  • High encapsulation efficiency
  • Developed industrial process and scalability
  • Stable, simple and solvent-free technologies
  • Reformulation of drugs near patent expiration
  • Development of drugs previously thought impossible
  • New administration routes for a variety of molecules
Quick Contact Platform Technology